Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril Folic Acid Combined with Amlodipine or Hydrochlorothiazide for Stroke Prevention in Type H Hypertension
NCT04952051Phase 3Completed
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jul 2014
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enalapril + folic acid in hypertension (HTN), hyperhomocysteinemia, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Jul 2014; status: completed.
02
Drugs
enalapril + folic acid
03
Conditions
hypertension (HTN)hyperhomocysteinemia
Beyond the preview
Go deeper on NCT04952051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04952051.